The Senior Director, Global Study Start-Up (SSU) leads study start-up strategy, talent, and execution across AbbVie’s portfolio. This role oversees the AbbVie Global Study Startup group and drives consistent, high-quality delivery of global start-up milestones through talent leadership, proactive risk management, standardized and continuously improved processes, and scaled adoption of AI-enabled ways of working. It partners with Clinical Study Leadership, Regulatory, Clinical Site Management, and other stakeholders to accelerate study activation while maintaining compliance. The position defines the long-term vision, strategy, and operating model for the Global Study Start-Up organization; establishes enterprise standards, governance, and performance expectations across therapeutic areas and geographies; and leads organizational design, workforce strategies, and transformation initiatives. It provides strategic oversight of portfolio start-up performance and advises senior Clinical Development and therapeutic area leaders on feasibility, activation strategy, resource allocation, and execution risk. The role also advances modernization through AI, automation, predictive analytics, and digital technologies; represents Study Start-Up in enterprise forums; builds leadership and organizational capability; and represents AbbVie in industry forums and strategic partnerships. The role reports to the Vice President, Neuroscience Clinical Study Leadership and Global Study Start Up. Key stakeholders include the R&D Leadership team and Country Affiliate leadership.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior